pk 11195 has been researched along with Degenerative Diseases, Central Nervous System in 13 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Excerpt | Relevance | Reference |
---|---|---|
"In general, neurodegenerative diseases have unpredictable clinical courses and timely effective treatment is not available." | 2.43 | Nuclear imaging of inflammation in neurologic and psychiatric disorders. ( de Vries, EF; Dierckx, RA; Klein, HC, 2006) |
"Striatal gliosis induced by 3-NP treatment was prevented by (+/-)-huprine Y pretreatment, as demonstrated by the attenuation of both the increase in [(3)H]PK 11195 specific binding indicative of microgliosis and the expression of hsp27 kDa, a chaperone expressed mainly in astrocytes." | 1.32 | Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage. ( Camins, A; Camps, P; Canudas, AM; Jiménez, A; Muñoz-Torrero, D; Pallàs, M; Pubill, D; Sureda, FX; Verdaguer, E, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (69.23) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scarf, AM | 1 |
Ittner, LM | 1 |
Kassiou, M | 1 |
Best, L | 1 |
Ghadery, C | 1 |
Pavese, N | 1 |
Tai, YF | 1 |
Strafella, AP | 1 |
Walberer, M | 1 |
Jantzen, SU | 1 |
Backes, H | 1 |
Rueger, MA | 1 |
Keuters, MH | 1 |
Neumaier, B | 1 |
Hoehn, M | 1 |
Fink, GR | 1 |
Graf, R | 1 |
Schroeter, M | 1 |
Milenkovic, VM | 1 |
Rupprecht, R | 1 |
Wetzel, CH | 1 |
Middleton, RJ | 1 |
Liu, GJ | 1 |
Banati, RB | 1 |
de Vries, EF | 1 |
Dierckx, RA | 1 |
Klein, HC | 1 |
Ouchi, Y | 1 |
Canudas, AM | 1 |
Pubill, D | 1 |
Sureda, FX | 1 |
Verdaguer, E | 1 |
Camps, P | 1 |
Muñoz-Torrero, D | 1 |
Jiménez, A | 1 |
Camins, A | 1 |
Pallàs, M | 1 |
Wilms, H | 1 |
Claasen, J | 1 |
Röhl, C | 1 |
Sievers, J | 1 |
Deuschl, G | 1 |
Lucius, R | 1 |
Belloli, S | 1 |
Moresco, RM | 1 |
Matarrese, M | 1 |
Biella, G | 1 |
Sanvito, F | 1 |
Simonelli, P | 1 |
Turolla, E | 1 |
Olivieri, S | 1 |
Cappelli, A | 1 |
Vomero, S | 1 |
Galli-Kienle, M | 1 |
Fazio, F | 1 |
Gerhard, A | 1 |
Trender-Gerhard, I | 1 |
Turkheimer, F | 1 |
Quinn, NP | 1 |
Bhatia, KP | 1 |
Brooks, DJ | 1 |
Maeda, J | 1 |
Higuchi, M | 1 |
Suhara, T | 1 |
Vas, A | 1 |
Shchukin, Y | 1 |
Karrenbauer, VD | 1 |
Cselényi, Z | 1 |
Kostulas, K | 1 |
Hillert, J | 1 |
Savic, I | 1 |
Takano, A | 1 |
Halldin, C | 1 |
Gulyás, B | 1 |
7 reviews available for pk 11195 and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
The translocator protein (18 kDa): central nervous system disease and drug design.
Topics: Acetamides; Apoptosis; Central Nervous System; Central Nervous System Diseases; Drug Design; Humans; | 2009 |
New and Old TSPO PET Radioligands for Imaging Brain Microglial Activation in Neurodegenerative Disease.
Topics: Animals; Brain; Humans; Isoquinolines; Microglia; Neurodegenerative Diseases; Neuroimaging; Positron | 2019 |
The Translocator Protein 18 kDa (TSPO) and Its Role in Mitochondrial Biology and Psychiatric Disorders.
Topics: Antipsychotic Agents; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Isoquinol | 2015 |
Guwiyang Wurra--'Fire Mouse': a global gene knockout model for TSPO/PBR drug development, loss-of-function and mechanisms of compensation studies.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Energy Metabolism; Inflamm | 2015 |
Nuclear imaging of inflammation in neurologic and psychiatric disorders.
Topics: Anti-Bacterial Agents; Antiviral Agents; Carbon Radioisotopes; Cyclooxygenase 2; Encephalitis; Human | 2006 |
[Imaging of brain microgliosis by PET].
Topics: Animals; Brain; Carbon Radioisotopes; Cytokines; Humans; Isoquinolines; Mental Disorders; Microglia; | 2009 |
[Imaging of glial cells by positron-emitted peripheral benzodiazepine receptor ligands].
Topics: Acetamides; Animals; Biomarkers; Carbon Radioisotopes; Gliosis; Humans; Isoquinolines; Ligands; Neur | 2006 |
1 trial available for pk 11195 and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Functional neuroimaging in multiple sclerosis with radiolabelled glia markers: preliminary comparative PET studies with [11C]vinpocetine and [11C]PK11195 in patients.
Topics: Adult; Anticonvulsants; Antineoplastic Agents; Binding, Competitive; Biomarkers; Brain Mapping; Carb | 2008 |
5 other studies available for pk 11195 and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
In-vivo detection of inflammation and neurodegeneration in the chronic phase after permanent embolic stroke in rats.
Topics: Amyloid; Animals; Brain; Carbon Radioisotopes; Chronic Disease; Disease Models, Animal; Immunohistoc | 2014 |
Neuroprotective effects of (+/-)-huprine Y on in vitro and in vivo models of excitoxicity damage.
Topics: Aminoquinolines; Animals; Binding, Competitive; Calcium; Cell Death; Cells, Cultured; Cerebellum; Co | 2003 |
Involvement of benzodiazepine receptors in neuroinflammatory and neurodegenerative diseases: evidence from activated microglial cells in vitro.
Topics: Animals; Animals, Newborn; Benzodiazepines; Binding Sites; Cell Division; Cells, Cultured; Encephali | 2003 |
Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration.
Topics: Amides; Animals; Immunohistochemistry; Isoquinolines; Ligands; Male; Neurodegenerative Diseases; Qui | 2004 |
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in progressive supranuclear palsy.
Topics: Aged; Basal Ganglia; Brain Stem; Carbon Radioisotopes; Cell Death; Female; Frontal Lobe; Humans; Ima | 2006 |